SEI Investments’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

SEI Investments’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5	Closed	–	–	3522
2018 Q2	$0	Buy	+5	New	+$229	﹤0.01%	3831
2018 Q1	–	Hold	0	–	–	–	3707
2017 Q4	–	Hold	0	–	–	–	3530
2015 Q4	–	Sell	-2,655	Closed	-$856K	–	2717
2015 Q3	$856K	Buy	2,655 +2,640	+17,600%	+$1.16M	0.01%	1085
2015 Q2	$7K	Sell	15 -2	-12%	-$850	﹤0.01%	1967
2015 Q1	$7K	Buy	17 +3	+21%	+$1.16K	﹤0.01%	1974
2014 Q4	$4K	Buy	+14	New	+$4.17K	﹤0.01%	2002

Other funds holding LUMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SEI Investments's LUMO Position: Q3 2018 in Review

SEI Investments sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2018, closing a stake of 5 shares.

SEI Investments first reported a position in LUMO in Q4 2014 and held it in 5 quarters. The position peaked at $856K in Q3 2015. 92 funds tracked by Wall St. Rank hold LUMO as of Q3 2018.

SEI Investments reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
SEI Investments sold 5 Lumos Pharma, Inc. Common Stock shares in Q3 2018.
SEI Investments first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 5 quarters.
SEI Investments's Lumos Pharma, Inc. Common Stock position peaked at $856K in Q3 2015.
92 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.